- Home
- ISDR vs FBIO Comparison
ISDR vs FBIO Comparison
Compare ISDR & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISDR
- FBIO
- Stock Information
- Founded
- ISDR 1988
- FBIO 2006
- Country
- ISDR United States
- FBIO United States
- Employees
- ISDR N/A
- FBIO N/A
- Industry
- ISDR Publishing
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ISDR Consumer Discretionary
- FBIO Health Care
- Exchange
- ISDR Nasdaq
- FBIO Nasdaq
- Market Cap
- ISDR N/A
- FBIO 48.2M
- IPO Year
- ISDR N/A
- FBIO N/A
- Fundamental
- Price
- ISDR $10.88
- FBIO $1.81
- Analyst Decision
- ISDR
- FBIO Strong Buy
- Analyst Count
- ISDR 0
- FBIO 4
- Target Price
- ISDR N/A
- FBIO $16.33
- AVG Volume (30 Days)
- ISDR 12.8K
- FBIO 957.9K
- Earning Date
- ISDR 11-07-2024
- FBIO 11-12-2024
- Dividend Yield
- ISDR N/A
- FBIO N/A
- EPS Growth
- ISDR N/A
- FBIO N/A
- EPS
- ISDR N/A
- FBIO N/A
- Revenue
- ISDR $29,757,000.00
- FBIO $82,624,000.00
- Revenue This Year
- ISDR N/A
- FBIO N/A
- Revenue Next Year
- ISDR N/A
- FBIO $81.63
- P/E Ratio
- ISDR N/A
- FBIO N/A
- Revenue Growth
- ISDR N/A
- FBIO 31.68
- 52 Week Low
- ISDR $7.61
- FBIO $1.24
- 52 Week High
- ISDR $19.03
- FBIO $4.43
- Technical
- Relative Strength Index (RSI)
- ISDR 53.88
- FBIO 60.07
- Support Level
- ISDR $9.71
- FBIO $1.50
- Resistance Level
- ISDR $11.40
- FBIO $1.65
- Average True Range (ATR)
- ISDR 0.50
- FBIO 0.08
- MACD
- ISDR -0.02
- FBIO 0.04
- Stochastic Oscillator
- ISDR 51.54
- FBIO 91.11
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.